SHOULDER INNOVATIONS, INC. Revenue
SHOULDER INNOVATIONS, INC. (SI) reported Revenue of $17.18 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-08-06
- SHOULDER INNOVATIONS, INC. revenues for the quarter ending 2026-06-30 was $17.18M, a 55.95% increase year-over-year.
- SHOULDER INNOVATIONS, INC. revenues for the quarter ending 2026-03-31 was $16.71M, a 64.90% increase year-over-year.
- SHOULDER INNOVATIONS, INC. revenues for the quarter ending 2025-12-31 was $14.42M, a 65.23% increase year-over-year.
- SHOULDER INNOVATIONS, INC. revenues for the quarter ending 2025-09-30 was $11.76M, a 57.71% increase year-over-year.
- SHOULDER INNOVATIONS, INC. revenues for fiscal 2025 was $47.32M, a 49.63% increase from fiscal 2024.
- SHOULDER INNOVATIONS, INC. revenues for fiscal 2024 was $31.62M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2026-06-30 | $17.18M 10-Q · filed 2026-08-06 | $33.88M 10-Q · filed 2026-08-06 | $48.30M derived: sum of 3 quarters · filed 2026-08-06 | $60.05M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $16.71M 10-Q · filed 2026-05-13 | $31.12M derived: sum of 2 quarters · filed 2026-05-13 | $42.88M derived: sum of 3 quarters · filed 2026-05-13 | $53.89M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $14.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $26.17M derived: sum of 2 quarters · filed 2026-03-10 | $37.19M derived: sum of 3 quarters · filed 2026-08-06 | $47.32M 10-K · filed 2026-03-10 |
| 2025-09-30 | $11.76M 10-Q · filed 2025-11-12 | $22.77M derived: sum of 2 quarters · filed 2026-08-06 | $32.90M 10-Q · filed 2025-11-12 | $41.63M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $11.01M 10-Q · filed 2026-08-06 | $21.14M 10-Q · filed 2026-08-06 | $29.87M derived: sum of 3 quarters · filed 2026-08-06 | $37.32M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $10.13M 10-Q · filed 2026-05-13 | $18.86M derived: sum of 2 quarters · filed 2026-05-13 | $26.31M derived: sum of 3 quarters · filed 2026-05-13 | $34.57M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $8.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $16.18M derived: sum of 2 quarters · filed 2026-03-10 | $24.44M derived: sum of 3 quarters · filed 2026-03-10 | $31.62M 10-K · filed 2026-03-10 |
| 2024-09-30 | $7.45M 10-Q · filed 2025-11-12 | $15.71M derived: sum of 2 quarters · filed 2025-11-12 | $22.90M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $8.26M 10-Q · filed 2025-09-09 | $15.44M 10-Q · filed 2025-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |